{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:27:27Z","timestamp":1787506047563,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.steroids.2006.05.005","type":"journal-article","created":{"date-parts":[[2006,6,19]],"date-time":"2006-06-19T09:44:00Z","timestamp":1150710240000},"page":"751-759","source":"Crossref","is-referenced-by-count":24,"title":["Steroidogenic alterations and adrenal androgen excess in PCOS"],"prefix":"10.1016","volume":"71","author":[{"given":"Suhail A.R.","family":"Doi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Al-Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Towers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal A.S.","family":"Al-Shoumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2265.2003.01858.x","article-title":"Adrenarche \u2013 physiology, biochemistry and human disease","volume":"60","author":"Auchus","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.steroids.2006.05.005_bib2","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1210\/jc.2003-030143","article-title":"The 17,20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway","volume":"88","author":"Fluck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"10.1016\/j.steroids.2006.05.005_bib3","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1046\/j.1432-1033.2002.03268.x","article-title":"Baboon cytochrome P450 17alpha-hydroxylase\/17,20-lyase (CYP17)","volume":"269","author":"Swart","year":"2002","journal-title":"Eur J Biochem"},{"issue":"14","key":"10.1016\/j.steroids.2006.05.005_bib4","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1021\/bi00517a014","article-title":"Microsomal cytochrome P-450 from neonatal pig testis: two enzymatic activities (17 alpha-hydroxylase and c17,20-lyase) associated with one protein","volume":"20","author":"Nakajin","year":"1981","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.steroids.2006.05.005_bib5","doi-asserted-by":"crossref","first-page":"15992","DOI":"10.1016\/S0021-9258(18)98506-6","article-title":"Missense mutation serine106\u2014proline causes 17 alpha-hydroxylase deficiency","volume":"266","author":"Lin","year":"1991","journal-title":"J Biol Chem"},{"issue":"4781","key":"10.1016\/j.steroids.2006.05.005_bib6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.3535074","article-title":"Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells","volume":"234","author":"Zuber","year":"1986","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1210\/er.18.3.281","article-title":"Molecular endocrinology of hydroxysteroid dehydrogenases","volume":"18","author":"Penning","year":"1997","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib8","first-page":"342","article-title":"Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis","volume":"15","author":"Simpson","year":"1994","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib9","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/en.132.6.2498","article-title":"Steroid 17 alpha-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase","volume":"132","author":"Lin","year":"1993","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib10","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejogrb.2004.06.024","article-title":"PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?","volume":"118","author":"Doi","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"10.1016\/j.steroids.2006.05.005_bib12","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jc.86.12.5925","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.steroids.2006.05.005_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/jc.2003-030934","article-title":"The hormonal phenotype of nonclassic 3 beta-hydroxysteroid dehydrogenase (HSD3B) deficiency in hyperandrogenic females is associated with insulin-resistant polycystic ovary syndrome and is not a variant of inherited HSD3B2 deficiency","volume":"89","author":"Carbunaru","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1210\/jcem-62-1-142","article-title":"Adrenal abnormalities in polycystic ovary syndrome","volume":"62","author":"Loughlin","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)","volume":"62","author":"Kumar","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/09513599009024976","article-title":"Pituitary-adrenal responses to ovine corticotropin-releasing factor in polycystic ovary syndrome and in other hyperandrogenic patients","volume":"4","author":"Carmina","year":"1990","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.steroids.2006.05.005_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2007-1016296","article-title":"Adrenal involvement in polycystic ovary syndrome","volume":"15","author":"Gonzalez","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0029-7844(95)00065-Y","article-title":"Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome","volume":"85","author":"Carmina","year":"1995","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1210\/jc.75.3.768","article-title":"The ovarian contribution to peripherally derived serum C19 conjugates","volume":"75","author":"Matteri","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0002-9378(91)90280-5","article-title":"Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome","volume":"165","author":"Gonzalez","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.fertnstert.2004.05.068","article-title":"Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome","volume":"82","author":"Kahsar-Miller","year":"2004","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.steroids.2006.05.005_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2004.10.027","article-title":"Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess","volume":"83","author":"Witchel","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2006.05.005_bib23","doi-asserted-by":"crossref","unstructured":"ESHRE\/ASRM. The Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19(1):41\u201347.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.steroids.2006.05.005_bib24","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2133.1993.tb00168.x","article-title":"Semiquantitative assessment of hirsutism in Dutch women","volume":"128","author":"Derksen","year":"1993","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.steroids.2006.05.005_bib26","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1210\/jc.82.11.3728","article-title":"Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity","volume":"82","author":"Arroyo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jcem-70-4-1114","article-title":"Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity","volume":"70","author":"Campbell","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2006.05.005_bib28","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1210\/jc.85.12.4426","article-title":"Insulin sensitivity and its measurement: structural commonalities among the methods","volume":"85","author":"Radziuk","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2006.05.005_bib29","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1210\/jc.86.11.5457","article-title":"Repeatability characteristics of simple indices of insulin resistance: implications for research applications","volume":"86","author":"Mather","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.steroids.2006.05.005_bib30","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.steroids.2006.05.005_bib31","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1210\/jc.86.10.4615","article-title":"Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity","volume":"86","author":"Quon","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0015-0282(99)00468-9","article-title":"Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity","volume":"73","author":"Mather","year":"2000","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.steroids.2006.05.005_bib33","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/humrep\/14.7.1684","article-title":"Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome","volume":"14","author":"van Hooff","year":"1999","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.steroids.2006.05.005_bib34","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1093\/humrep\/dei093","article-title":"Irregular cycles and steroid hormones in polycystic ovary syndrome","volume":"20","author":"Doi","year":"2005","journal-title":"Hum Reprod"},{"issue":"6543","key":"10.1016\/j.steroids.2006.05.005_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1479-828X.1993.tb02125.x","article-title":"Idiopathic hirsutism or polycystic ovary syndrome?","volume":"33","author":"Jahanfar","year":"1993","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.steroids.2006.05.005_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0015-0282(98)00455-5","article-title":"Do hyperandrogenic women with normal menses have polycystic ovary syndrome?","volume":"71","author":"Carmina","year":"1999","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.steroids.2006.05.005_bib38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(01)00979-2","article-title":"Polycystic ovaries in hirsute women with normal menses","volume":"111","author":"Carmina","year":"2001","journal-title":"Am J Med"},{"issue":"25","key":"10.1016\/j.steroids.2006.05.005_bib39","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.steroids.2006.05.005_bib40","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0026-0495(97)90077-9","article-title":"Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?","volume":"46","author":"Escobar-Morreale","year":"1997","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib41","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1210\/jc.87.6.2611","article-title":"Newly proposed hormonal criteria via genotypic proof for type II 3beta-hydroxysteroid dehydrogenase deficiency","volume":"87","author":"Lutfallah","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2265.2003.01716.x","article-title":"Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test","volume":"58","author":"Pang","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib43","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0015-0282(16)49874-2","article-title":"Normal ovarian function in a mild form of late-onset 3 beta- hydroxysteroid dehydrogenase deficiency","volume":"46","author":"Medina","year":"1986","journal-title":"Fertil Steril"},{"issue":"11","key":"10.1016\/j.steroids.2006.05.005_bib44","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/jc.81.11.3961","article-title":"Studies of 3 beta-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels","volume":"81","author":"Sakkal-Alkaddour","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib45","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1203\/00006450-199506000-00024","article-title":"Absence of molecular defect in the type II 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta-HSD activity","volume":"37","author":"Chang","year":"1995","journal-title":"Pediatr Res"},{"issue":"1\u20133","key":"10.1016\/j.steroids.2006.05.005_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0960-0760(93)90130-O","article-title":"The pathogenesis of adrenal and extra adrenal hyperandrogenism","volume":"45","author":"McKenna","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.steroids.2006.05.005_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/eje.0.1380567","article-title":"Intra-adrenal factors are not involved in the differential control of cortisol and adrenal androgens in human adrenals","volume":"138","author":"Fearon","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.steroids.2006.05.005_bib48","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1210\/jc.83.7.2317","article-title":"Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/jcem-59-1-13","article-title":"Dissociation of cortisol and adrenal androgen secretion in the hypophysectomized, adrenocorticotropin-replaced chimpanzee","volume":"59","author":"Albertson","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/eje.0.1430383","article-title":"Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection","volume":"143","author":"Wu","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib51","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0015-0282(16)57474-3","article-title":"Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome","volume":"63","author":"Fruzzetti","year":"1995","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.steroids.2006.05.005_bib52","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0015-0282(16)58267-3","article-title":"Ovarian hyperstimulation augments adrenal dehydroepiandrosterone sulfate secretion","volume":"65","author":"Casson","year":"1996","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.steroids.2006.05.005_bib53","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1210\/jc.81.9.3299","article-title":"The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.steroids.2006.05.005_bib54","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1210\/jc.82.7.2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.steroids.2006.05.005_bib55","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.steroids.2006.05.005_bib56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.steroids.2006.05.005_bib57","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/humrep\/deg343","article-title":"Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin","volume":"18","author":"Glueck","year":"2003","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib58","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0015-0282(99)00407-0","article-title":"Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome","volume":"72","author":"la Marca","year":"1999","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.steroids.2006.05.005_bib59","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jc.85.8.2767","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1440619","article-title":"The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"144","author":"Vrbikova","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.steroids.2006.05.005_bib61","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/humrep\/16.8.1625","article-title":"Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial","volume":"16","author":"Ng","year":"2001","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib62","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(02)04914-2","article-title":"Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome","volume":"79","author":"Azziz","year":"2003","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","article-title":"Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion","volume":"16","author":"Ehrmann","year":"1995","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib64","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1210\/jcem-72-4-883","article-title":"Effect of acute physiological elevations of insulin on circulating androgen levels in nonobese women","volume":"72","author":"Diamond","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib65","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0015-0282(16)56212-8","article-title":"The influence of luteinizing hormone and insulin on sex steroids and sex hormone-binding globulin in the polycystic ovarian syndrome","volume":"60","author":"Buyalos","year":"1993","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib66","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1210\/jcem-64-1-180","article-title":"The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans","volume":"64","author":"Nestler","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib67","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jcem-71-6-1653","article-title":"Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women","volume":"71","author":"Falcone","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0015-0282(16)59293-0","article-title":"Androgen and insulin response to an oral glucose challenge in hyperandrogenic women","volume":"48","author":"Smith","year":"1987","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.steroids.2006.05.005_bib69","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1210\/jcem-69-5-1040","article-title":"Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms","volume":"69","author":"Nestler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.steroids.2006.05.005_bib70","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1210\/jc.74.2.362","article-title":"Insulin inhibits adrenal 17,20-lyase activity in man","volume":"74","author":"Nestler","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib71","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.81.3.881","article-title":"Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib72","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.87.4.1555","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.steroids.2006.05.005_bib73","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1210\/jc.82.12.4075","article-title":"Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens","volume":"82","author":"Nestler","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/humrep\/15.1.21","article-title":"Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance- related polycystic ovary syndrome","volume":"15","author":"la Marca","year":"2000","journal-title":"Hum Reprod"},{"issue":"20","key":"10.1016\/j.steroids.2006.05.005_bib75","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3beta -hydroxysteroid dehydrogenase","volume":"276","author":"Arlt","year":"2001","journal-title":"J Biol Chem"},{"issue":"11\u201312","key":"10.1016\/j.steroids.2006.05.005_bib76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-2002-38265","article-title":"Adipose tissue intracrinology: potential importance of local androgen\/estrogen metabolism in the regulation of adiposity","volume":"34","author":"Belanger","year":"2002","journal-title":"Horm Metab Res"},{"issue":"11\u201312","key":"10.1016\/j.steroids.2006.05.005_bib77","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1055\/s-2002-38249","article-title":"Sex steroid biosynthesis in white adipose tissue","volume":"34","author":"Meseguer","year":"2002","journal-title":"Horm Metab Res"},{"issue":"6","key":"10.1016\/j.steroids.2006.05.005_bib78","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0026-0495(98)90186-X","article-title":"Hyperinsulinemia and sex hormones in healthy premenopausal women: relative contribution of obesity, obesity type, and duration of obesity","volume":"47","author":"Ivandic","year":"1998","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib80","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0026-0495(96)90202-4","article-title":"The impact of obesity on hormonal parameters in hirsute and nonhirsute women","volume":"45","author":"Bernasconi","year":"1996","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib81","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/humrep\/10.1.75","article-title":"Metabolic regulation of androgen production by human thecal cells in vitro","volume":"10","author":"Nahum","year":"1995","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.steroids.2006.05.005_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","article-title":"On the paradox of insulin-induced hyperandrogenism in insulin-resistant states","volume":"12","author":"Poretsky","year":"1991","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.steroids.2006.05.005_bib83","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0015-0282(16)47243-2","article-title":"Effects of insulin on steroidogenesis in cultured porcine ovarian theca","volume":"40","author":"Barbieri","year":"1983","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib84","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil Steril"},{"issue":"1\u20132","key":"10.1016\/j.steroids.2006.05.005_bib85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0303-7207(01)00469-5","article-title":"Gonadotropic control of ovarian follicular growth and development","volume":"179","author":"Hillier","year":"2001","journal-title":"Mol Cell Endocrinol"},{"issue":"12","key":"10.1016\/j.steroids.2006.05.005_bib86","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1210\/me.7.12.1561","article-title":"Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein 1 gene transcription by hormones and provision of amino acids in rat hepatocytes","volume":"7","author":"Pao","year":"1993","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.steroids.2006.05.005_bib87","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/endo-122-2-581","article-title":"The effects of experimental hyperinsulinemia on steroid secretion, ovarian","volume":"122","author":"Poretsky","year":"1988","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.steroids.2006.05.005_bib88","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/jc.85.4.1598","article-title":"Effect of metformin on insulin-like growth factor (IGF) I and IGF- binding protein I in polycystic ovary syndrome","volume":"85","author":"De Leo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.steroids.2006.05.005_bib89","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/humrep\/deh145","article-title":"Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome","volume":"19","author":"Guido","year":"2004","journal-title":"Hum Reprod"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X06001097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X06001097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T10:03:45Z","timestamp":1627466625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X06001097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0039128X06001097"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2006.05.005","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}